Steffen H M, Brunner R, Müller R, Degenhardt S, Pollok M, Lang R, Baldamus C A
Medical Clinic II, Eye Clinic, University of Cologne, FRG.
Contrib Nephrol. 1989;76:292-8. doi: 10.1159/000417905.
Treatment of renal anemia with rhEPO (120 U/kg body weight/hemodialysis) in transfusion-dependent patients on maintenance hemodialysis led to an increase in blood pressure, regional peripheral resistance and whole blood viscosity. Our results are in agreement with earlier findings that partial correction of renal anemia results in hemodynamic changes characterized by a fall in cardiac output together with an increase in blood pressure due to increased vascular resistance. The increase in whole blood viscosity correlated with the increase in regional peripheral resistance but not with the increase in mean arterial blood pressure. Thus, other regulating factors of vascular resistance must be involved. Correction of renal anemia does not influence the reninangiotensin system. However, peripheral responsiveness of vascular smooth muscles may have changed due to improved tissue oxygenation and thus leading to an increase in vasoconstriction.
在维持性血液透析的输血依赖患者中,使用重组人促红细胞生成素(rhEPO,120 U/kg体重/血液透析)治疗肾性贫血会导致血压、局部外周阻力和全血粘度升高。我们的结果与早期研究结果一致,即肾性贫血的部分纠正会导致血流动力学变化,其特征是心输出量下降,同时由于血管阻力增加导致血压升高。全血粘度的增加与局部外周阻力的增加相关,但与平均动脉血压的增加无关。因此,必然涉及血管阻力的其他调节因素。肾性贫血的纠正不会影响肾素-血管紧张素系统。然而,由于组织氧合改善,血管平滑肌的外周反应性可能发生了变化,从而导致血管收缩增加。